|
News Release |
1001
Connecticut Ave, NW - Ste 710 - Washington, DC 20036 |
May 21, 1998
House Amendment To Higher Education Bill Bars
Marijuana Smokers
From Receiving Student Aid
May 21, 1998, Washington, D.C.:
The House overwhelmingly approved legislation this month denying convicted
marijuana offenders from receiving federal student loan assistance. The language,
introduced by Rep. Mark Souder (R-Ind.) as House Amendment 582 to the Higher Education
Programs Authorization Extension Bill (H.R. 6), mandates that "An individual student
who has been convicted of any offense under any Federal or State law involving the
possession or sale of a controlled substance shall not be eligible to receive any
[federal] grant, loan, or work assistance."
NORML National Campus Coordinator Aaron Wilson
said that the legislation unfairly punishes marijuana users. "It is outrageous
that Congress would pass this law denying financial aid to students for minor non-violent
drug offenses, while a felony conviction for a serious violent crime brings no such
penalty," he said. "What kind of message is Congress sending?"
Souder's amendment suspends first time drug
offenders from receiving student aid for a period of one year. Second time offenders
will be ineligible for two years, and multiple repeat offenders will be barred
indefinitely. Drug sellers will be ineligible for two years after their first
conviction, and indefinitely prohibited from receiving aid upon a second conviction.
Students may resume eligibility before the completion of their suspension if they
participate in a drug rehabilitation program and pass two random drug tests.
Wilson questioned how fairly the new law would
apply to marijuana offenders. "In many states, marijuana possession is
decriminalized (a civil violation punishable by payment of a small fine), while in others
it's a misdemeanor or a felony. Depending on which state students live in, this
legislation may or may not apply to you."
The House approved H.R. 6 by a vote of 414 to
4, far exceeding the two-thirds majority necessary to override a veto by President
Clinton. The bill now awaits action from the Senate.
For more information, please contact either
Keith Stroup, Esq. of NORML @ (202) 483-5500 or Aaron Wilson @ (212) 362-1964.
Medical Marijuana Distribution Summit To Take Place Next Week
May 21, 1998, Sacramento, CA:
The California State Senate Committee on Public Safety hosts a forum next week to
determine alternate methods of distributing medical marijuana to seriously ill California
patients. The summit, organized by Rep. John Vasconcellos (D-Santa Clara), marks the
first large scale legislative effort to "implement a plan to provide for the safe and
affordable distribution of [medical] marijuana" specified by the passage of
Proposition 215.
"This summit is to see whether we can find
some way to assure safe access to medical marijuana for sick Californians,"
Vasconcellos said. Representatives from the medical marijuana reform community,
state health agencies, and law enforcement, as well as district attorneys from around the
state will participate in the summit. United States Justice Department officials,
including Attorney General Janet Reno, declined to attend the meeting.
California NORML Coordinator Dale Gieringer
suggested that private medical marijuana dispensaries remain the best alternative for
distributing the drug to patients. "Experience has shown that well-run patient
cooperatives offer benefits to both public health and safety," he said. "[They
give] patients a safe, reliable, accountable source of medicine and relieve them of the
need to rely on illicit street traffickers. State legislation should therefore focus
on legitimizing and regulating the operation of cannabis patients' cooperatives until such
time as federal law is changed to permit other alternatives."
The federal Controlled Substances Act forbids
the distribution of a Schedule I controlled substance -- including marijuana -- to any
patient outside of a strictly controlled research project approved by the Drug Enforcement
Administration (DEA).
San Francisco District Attorney Terrence
Hallinan backed a plan that will allow the city to distribute medical marijuana.
"My feeling is that if it is done properly by a health department, ... the
federal government will pass on it, as they do with the needle exchange."
A spokesman from state District Attorney Dan
Lungren's office will also attend the summit, but only to reaffirm the D.A.'s position
that no distribution of medical marijuana is legal in California.
Vasconcellos' office said they hope to bring a
state-sponsored medical marijuana distribution proposal before the California Legislature
later this year.
For more information, please contact either
Dale Gieringer of California NORML @ (415) 563-5858 or Dave Fratello of Americans for
Medical Rights @ (310) 394-2952.
California County Allocates Funding For Medical Marijuana Study
May 21, 1998, Redwood City,
California: San Mateo County officials appropriated $50,000 to design a
three-year research project to study marijuana's therapeutic effects on patients.
The decision marks the third time in recent years officials in a state have
endorsed establishing a state-run medical marijuana research program. Prior
state-backed protocols in Washington state in 1996 and Massachusetts in 1997 failed to
gain approval from federal officials and were never implemented.
"We see this as the best and only
alternative to legitimize the use of medical marijuana," said Margaret Taylor, the
county's health director. "This is about taking care of people with medical
problems."
Taylor said that it will take several months to
prepare a formal protocol for the clinical study, but estimated that as many as 2,000
patients may qualify. If approved by the FDA, the study must then also be okayed by
either the Drug Enforcement Administration (DEA) or the National Institute on Drug Abuse
(NIDA) to move forward. Presently, neither agency supports the study of marijuana
for medical purposes.
Starting in the late 1970's, several states --
including California, Georgia, Michigan, New Mexico, New York, and Tennessee -- began
looking for ways to make marijuana available to patients despite the federal government's
blanket prohibition. Each state eventually passed laws establishing state-run
"controlled substances therapeutic research programs" where patients suffering
from specific illnesses could qualify to receive marijuana as part of their medical
treatment.
By the early 1980s, thousands of seriously ill
patients gained access to government-grown whole-smoked marijuana through these state
programs. The majority of patients and their physicians reported favorable results.
However, all state research abruptly ended by the late 1980's after the FDA
approved oral THC (Marinol) for prescription use and NIDA made acquiring marijuana for
medical research more difficult.
Presently, the California Legislature is
waiting to vote on a larger proposal to establish a "Medical Marijuana Research
Center" at a campus of the University of California.
For more information, please contact either
Dale Gieringer of California NORML @ (415) 563-5858 or Paul Armentano of NORML @ (202)
483-5500. Copies of NORML's publication: "Smoked Marijuana as an
Effective Treatment for Nausea and Vomiting Associated with Cancer Chemotherapy in Six
Separate State Clinical Trials: 1982-1986" are available from NORML upon
request.
-END-